Fernández O - Search Results

1

Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study.

Fernández O, Izquierdo G, Fernández V, Leyva L, Reyes V, Guerrero M, León A, Arnaiz C, Navarro G, Páramo MD, Cuesta A, Soria B, Hmadcha A, Pozo D, Fernandez-Montesinos R, Leal M, Ochotorena I, Gálvez P, Geniz MA, Barón FJ, Mata R, Medina C, Caparrós-Escudero C, Cardesa A, Cuende N; Research Group Study EudraCT 2008-004015-35. Fernández O, et al. Among authors: fernandez v, fernandez montesinos r. PLoS One. 2018 May 16;13(5):e0195891. doi: 10.1371/journal.pone.0195891. eCollection 2018. PLoS One. 2018. PMID: 29768414 Free PMC article. Clinical Trial.

2

Combination therapy with interferon beta-1b and azathioprine in secondary progressive multiple sclerosis. A two-year pilot study.

Fernández O, Guerrero M, Mayorga C, Muñoz L, Leán A, Luque G, Hervás M, Fernández V, Capdevila A, de Ramón E. Fernández O, et al. Among authors: fernandez v. J Neurol. 2002 Aug;249(8):1058-62. doi: 10.1007/s00415-002-0787-0. J Neurol. 2002. PMID: 12195454

3

Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression.

Matesanz F, Fedetz M, Leyva L, Delgado C, Fernández O, Alcina A. Matesanz F, et al. Among authors: fernandez o. J Neuroimmunol. 2004 Mar;148(1-2):212-7. doi: 10.1016/j.jneuroim.2003.12.001. J Neuroimmunol. 2004. PMID: 14975604

4

Protein tyrosine phosphatase gene (PTPN22) polymorphism in multiple sclerosis.

Matesanz F, Rueda B, Orozco G, Fernandez O, Leyva L, Alcina A, Martín J. Matesanz F, et al. Among authors: fernandez o. J Neurol. 2005 Aug;252(8):994-5. doi: 10.1007/s00415-005-0795-y. Epub 2005 Mar 17. J Neurol. 2005. PMID: 15765267 No abstract available.

5

IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response.

Leyva L, Fernández O, Fedetz M, Blanco E, Fernández VE, Oliver B, León A, Pinto-Medel MJ, Mayorga C, Guerrero M, Luque G, Alcina A, Matesanz F. Leyva L, et al. Among authors: fernandez o, fernandez ve. J Neuroimmunol. 2005 Jun;163(1-2):165-71. doi: 10.1016/j.jneuroim.2005.02.010. Epub 2005 Apr 22. J Neuroimmunol. 2005. PMID: 15885318

6

Interferon receptor expression in multiple sclerosis patients.

Oliver B, Mayorga C, Fernández V, Leyva L, León A, Luque G, López JC, Tamayo JA, Pinto-Medel MJ, de Ramon E, Blanco E, Alonso A, Fernández O. Oliver B, et al. Among authors: fernandez v, fernandez o. J Neuroimmunol. 2007 Feb;183(1-2):225-31. doi: 10.1016/j.jneuroim.2006.11.010. Epub 2006 Dec 26. J Neuroimmunol. 2007. PMID: 17188754

7

The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis.

Matesanz F, Fernández O, Milne RL, Fedetz M, Leyva L, Guerrero M, Delgado C, Lucas M, Izquierdo G, Alcina A. Matesanz F, et al. Among authors: fernandez o. J Neuroimmunol. 2008 Mar;195(1-2):146-50. doi: 10.1016/j.jneuroim.2008.01.004. Epub 2008 Mar 3. J Neuroimmunol. 2008. PMID: 18313765

8

IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D).

Alcina A, Fedetz M, Ndagire D, Fernández O, Leyva L, Guerrero M, Abad-Grau MM, Arnal C, Delgado C, Lucas M, Izquierdo G, Matesanz F. Alcina A, et al. Among authors: fernandez o. PLoS One. 2009;4(1):e4137. doi: 10.1371/journal.pone.0004137. Epub 2009 Jan 6. PLoS One. 2009. PMID: 19125193 Free PMC article.

9

HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Fernández O, R-Antigüedad A, Pinto-Medel MJ, Mendibe MM, Acosta N, Oliver B, Guerrero M, Papais-Alvarenga M, Fernández-Sánchez V, Leyva L. Fernández O, et al. Among authors: fernandez sanchez v. J Neurol. 2009 Dec;256(12):1977-88. doi: 10.1007/s00415-009-5223-2. J Neurol. 2009. PMID: 19585166

10

Does the DRB1*1501 allele confer more severe and faster progression in primary progressive multiple sclerosis patients? HLA in primary progressive multiple sclerosis.

Vasconcelos CC, Fernández O, Leyva L, Thuler LC, Alvarenga RM. Vasconcelos CC, et al. Among authors: fernandez o. J Neuroimmunol. 2009 Sep 29;214(1-2):101-3. doi: 10.1016/j.jneuroim.2009.06.009. Epub 2009 Jul 17. J Neuroimmunol. 2009. PMID: 19616314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

565 results

Search Page